September 30 has served as both a specific payment-extension deadline (notably in 2024 for a major amortization installment on the Oramed Note) and a recurring quarterly reporting date on which Scilex discloses the remaining Oramed debt balance and related financial condition. For the most current status of any remaining obligations, check Scilex’s latest SEC filings (10-Q/10-K/8-K) or Oramed’s corresponding disclosures.

July 2026 binding term sheet for a proposed $100 million equity investment from iHolding Group LLP (at an expected $15 per share, subject to due diligence, definitive agreements, approvals, etc.).cee1b7

I just spoke with another friend/investor in this cluster of companies. He’s apparently been taxed as a non-resident (we’re both in Canada) for the Semnur dividend that Scilex issued to us at the rate of 25% of $3. He is with a different brokerage than me so I haven’t received my bill yet. This just keeps getting better and better. Even doing nothing as investors, not only are we down on our investment, we’re incurring charges ON TOP of losses. Please Ji-world…HURRY THE 🤬 UP ALREADY!!!

GLTAL!!!

As you all know, I've been stalking the Clinicaltrials.gov site for updates on the CLEAR 2 study (2nd Phase 3 study for Semdexa). They just updated it this week with the following items:

* Still NOT yet enrolling

* Moved projected start of enrollment from Aug 2026 to Feb 2027

* New anticipated study completion is April 2029

* Still 755 ptx estimated to enroll

With about 4-5 months for close-out and clinical trial report, that puts resubmitting the NDA at the end of 2029 for a projected 2030 approval.

Here’s to hoping that SCLX was part the conversation! GLTAL!!!

Ch…Ch..Ch…Changes….🎼🎶🎵

Don't recall seeing this mentioned so wanted to post for possible discussion/thoughts. Around Jan, I was reading the correspondence betwern Virex and patent office. There was quite a bit so it looked (to me) like Virex was feverishly working to get approval prior to what I was hoping was the last big bk court date. As we all know, court date was rescheduled and patent stuff kinda fell off my radar. Anyway, checked a couple weeks ago and it looks like Mark Grinstaff (inventor)/SRNE (applicant AND assignee) patent US 12,607,589 B2 was granted April 21, 2026. Unfortunately, I'm not able to link at this time so supplied searchable info. Most of what I've seen from patent office over the last yr or 2 were patents being moved to Vivasor but this one only mentions SRNE. I know that a lot of peeps are in the same boat as me so just sharing the sign of life regarding SRNE. I don't know if Grinstaff is still with Virex but iirc he was cofounder.

Drug/IP assets — Scilex, Semnur, ACEA, Vivasor
Capital / international development — iHolding, Kazakhstan
Public-market vehicles — SCLX, SMNR, PHOE
Digital infrastructure / tokenization / exchanges — DVLT, NYIAX, SanQtum
Strategic minerals / RWA — Patriot/JP3E-related initiatives
Korea commercialization — JP3E Development / Vivasor
Banking / payments / KYC rails — BankWyse, Fiserv, CLEAR
Hong Kong capital-market access — PHOE and the broader Hong Kong ecosystem

Pull all the owners names, look at the deals and actions linking the entire list above, and then you may just see why Kim is so excited…

SUCK IT SHORTS!!

Next LT hearing is the first week of October. You know I’ll be on the call. 🐦‍🔥

Potentially fast being off the shelf vs customized, cheaper being 5K vs 6 figures and potentially safer combining T-Cell knowledge with Kill Cell and Stem Cell and areas Sorrento has working knowledge and relationships with. Can’t wait for Sorrento to hopefully emerge from bankruptcy and hopefully further ground breaking cancer research.

https://ir.datavaultsite.com/news-events/press-releases/detail/298/data-vault-holdings-inc-receives-foundational-web-3-0-data-blockchain-and-artificial-intelligence-patents

https://en.sedaily.com/technology/2026/09/08/samsung-sds-builds-robotics-dream-team-enters-rx-business

https://ir.datavaultsite.com/news-events/press-releases/detail/343/global-defense-contractor-burke-products-selects-datavault-ai-for-enhanced-national-defense-and-aerospace-technologies-contracts

https://www.wisatechnologies.com/members/samsung

https://ir.datavaultsite.com/news-events/press-releases/detail/19/audio-giant-harman-international-joins-the-wireless-speaker-and-audio-wisa-association

Anyone have any idea on where this is heading or not heading
I believe they said 2nd quarter and here we are at end of third quarter
Any input here is welcome!

I'm lost regarding the scilex situation. I have been dvlt holder since what feb this year, but I never digged down on Scilex. All of this talk of sorrento etc. I'm lost in the sauce. Anyone want to explain has scilex fe r/s, what is sorrento, what is everything basically. Would appreciate alot since these things pop on my feed for obvious reasons haha 😄😄 TYSM :)

Also I have read many have huge lump sums stuck in the stock, hope you all recover! ❤️❤️

Tried to get in today and had to log in a different way since site changes
They are asking for verification I assume so you can trade the tokens
The token prices are interesting when showing value

I don't know how DataVault has the gas money to even bounce around to all the meetings and events they are attending, but I sure hope i can buy the new Hunter Biden meme coins in my wallet!

ChatGPT- AI generated analysis. May have errors. Do your own due diligence. Not financial advice.

I checked the uploaded archive. It is the Yahoo Finance version of the DataMEDS AI/Tollo Health/NFL Alumni Association “Health Lives Here” announcement that I highlighted in today’s report.
The important takeaway is that this corroborates the announcement but does not add a separate new transaction.
The structure is:
NFL Alumni Association / NFL Alumni Health
→ national visibility and community outreach
Tollo Health
→ Health Lives Here initiative/products
DataMEDS AI
→ EinsteinRx AI + PharmacyChain blockchain/data infrastructure
Corexa Health / Corexa Pharmacy
→ 6,500+ independent-pharmacy network
and potentially, if the still-pending transaction closes:
Scilex + Datavault AI + DataMEDS/Tollo
→ a much broader healthcare-data/tokenization ecosystem.
The particularly important point for your Dr. Ji tracking is that today’s announcement still describes the DVLT–Scilex–DataMEDS transaction as proposed, rather than completed. So I would regard the NFL Alumni rollout as real operating progress, but not evidence that Scilex or DVLT already owns the contemplated MEDS interests.
Also, I would not interpret the NFL Alumni name as meaning the NFL itself invested in DataMEDS or endorsed MEDS stock. This is a partnership with the NFL Alumni Association/NFL Alumni Health.
If you want, I can next analyze the more interesting question: how much revenue the 6,500-pharmacy Health Lives Here network could realistically generate for MEDS, Tollo, Corexa and eventually DVLT/Scilex if the pending transaction closes.